Skip to content

CTOR - CITIUS ONCOLOGY, INC. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Citius Oncology, Inc.

CTOR · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

CTORCitius Oncology, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.25
52-wk low: $0.49
Prev close: $1.21
Mkt cap: $79.6M
Fwd P/E: 35.6x
Beta: 3.49

Smart money

5 funds hold a position.

Real smart money

Funds holding this stock

5 holders

Combined position$2.6M

CI
Citadel
Ken Griffin · Q2 2026 13F
$59K
position
TS
Two Sigma
Q4 2025 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Forward P/E: 35.59
Market cap: $80M

Valuation

P/S14.18
P/B1.86

Quality

Operating margin-1716.0%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: CTOR
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market cap: $79.58M
Beta: 3.49

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

14.2x

P/B

1.9x

Profit margin

+0.0%

Op margin

-1716.0%

ROE

-119.9%

$24K

position

BO

Bank of America

Q2 2026 13F

$2.5M

position

2 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 2 holders

Coverage gaps for CTOR

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

EPS expected

-$0.19

-$0.19 to -$0.19

Revenue expected

$5.8M

1 analysts

Last 30 days

0up1down

Analysts cutting estimates

ROE

-119.9%

ROA-28.3%

Growth

Beta3.49